We are passionate about helping you accelerate the development of cell and gene therapies to get new treatments to patients faster.
 
Our scientists and engineers are dedicated to developing new technology platforms that are specifically designed to increase pipeline efficiencies. Our portfolio of research and manufacturing media, non-viral transfection technologies, the Cocoon® Platform, for automated patient-scale cell therapy manufacturing, and primary cells can support you through every step of the cell and gene therapy process.
 
Together with our Cell and Gene Therapy Development and Manufacturing Services, we can help you to successfully navigate the path from early discovery to commercialization.